Share on LinkedInShare on LinkedIn

ARTICLE · 05 MARCH 2026

FTC Updates (February 2 – February 6, 2026)

Crowell & Moring LLP
Crowell & Moring LLP
Contributor
Crowell & Moring LLP

Crowell & Moring LLP

Crowell & Moring’s Doha office is a full service legal practice that serves as the firm’s regional...

View firm profile
Explore more from Crowell & Moring LLP

The FTC has been busy sending money to consumers harmed by unfair or deceptive business acts or practices.

United StatesConsumer Protection

The FTC has been busy sending money to consumers harmed by unfair or deceptive business acts or practices. The Commission has also announced a settlement with healthcare companies related to the cost of insulin drugs and released a recent report regarding it focus on privacy and cybersecurity. More on this news after the jump.

February 4, 2026

Bureau of Competition: Drug Stores and Pharmacies

  • The FTC secured a settlement with Express Scripts, Inc., and its affiliates (collectively "ESI"), resolving the Commission's lawsuit against ESI alleging that ESI artificially inflated the list price of insulin drugs, leading to the increase in cost of insulin to patients. The complaint further alleged that ESI, as well as other pharmacy benefit managers ("PBMs"), created a system of raising the list prices of drugs by preferencing rebates, pushing manufacturers to compete for preferred formulary coverage based on the size of rebates off the list price rather than net

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from